HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 297 filers reported holding HAEMONETICS CORP in Q3 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,256,606 | +6.9% | 81,007 | +1.6% | 0.00% | +50.0% |
| Q2 2023 | $6,786,170 | +4.5% | 79,706 | +1.5% | 0.00% | 0.0% |
| Q1 2023 | $6,496,456 | +6.4% | 78,507 | +1.1% | 0.00% | 0.0% |
| Q4 2022 | $6,104,815 | +6.8% | 77,620 | +0.5% | 0.00% | 0.0% |
| Q3 2022 | $5,716,000 | +11.9% | 77,214 | -1.5% | 0.00% | 0.0% |
| Q2 2022 | $5,109,000 | +9.3% | 78,384 | +6.0% | 0.00% | +100.0% |
| Q1 2022 | $4,675,000 | +19.6% | 73,945 | +0.3% | 0.00% | 0.0% |
| Q4 2021 | $3,909,000 | -24.7% | 73,713 | +0.2% | 0.00% | -50.0% |
| Q3 2021 | $5,192,000 | +21.2% | 73,553 | +14.5% | 0.00% | +100.0% |
| Q2 2021 | $4,283,000 | -66.5% | 64,263 | -44.2% | 0.00% | -80.0% |
| Q1 2021 | $12,794,000 | -6.0% | 115,249 | +0.5% | 0.01% | 0.0% |
| Q4 2020 | $13,614,000 | +18.1% | 114,646 | -13.3% | 0.01% | 0.0% |
| Q3 2020 | $11,532,000 | +5.4% | 132,171 | +8.2% | 0.01% | 0.0% |
| Q2 2020 | $10,945,000 | +18.5% | 122,209 | +31.8% | 0.01% | 0.0% |
| Q1 2020 | $9,238,000 | -14.5% | 92,688 | -1.5% | 0.01% | 0.0% |
| Q4 2019 | $10,811,000 | -0.6% | 94,094 | +9.1% | 0.01% | -16.7% |
| Q3 2019 | $10,875,000 | +5.7% | 86,212 | +0.8% | 0.01% | 0.0% |
| Q2 2019 | $10,291,000 | +98.3% | 85,516 | +44.1% | 0.01% | +100.0% |
| Q1 2019 | $5,190,000 | -11.3% | 59,335 | +1.5% | 0.00% | -40.0% |
| Q4 2018 | $5,849,000 | -8.6% | 58,456 | +4.6% | 0.01% | 0.0% |
| Q3 2018 | $6,402,000 | +26.1% | 55,877 | -1.3% | 0.01% | +25.0% |
| Q2 2018 | $5,075,000 | -37.4% | 56,599 | -49.0% | 0.00% | -33.3% |
| Q1 2018 | $8,107,000 | +31.8% | 110,980 | +4.8% | 0.01% | +50.0% |
| Q4 2017 | $6,153,000 | +30.8% | 105,917 | +0.9% | 0.00% | 0.0% |
| Q3 2017 | $4,703,000 | +19.3% | 104,958 | +5.1% | 0.00% | +33.3% |
| Q2 2017 | $3,943,000 | +6.4% | 99,893 | +9.4% | 0.00% | 0.0% |
| Q1 2017 | $3,706,000 | +1.8% | 91,350 | +0.8% | 0.00% | 0.0% |
| Q4 2016 | $3,641,000 | +107.7% | 90,617 | +86.7% | 0.00% | +50.0% |
| Q3 2016 | $1,753,000 | +371.2% | 48,533 | +274.1% | 0.00% | – |
| Q2 2016 | $372,000 | -7.9% | 12,974 | +11.5% | 0.00% | – |
| Q1 2016 | $404,000 | +14.1% | 11,638 | +7.0% | 0.00% | – |
| Q4 2015 | $354,000 | +10.6% | 10,879 | +9.2% | 0.00% | – |
| Q3 2015 | $320,000 | -22.5% | 9,958 | 0.0% | 0.00% | – |
| Q2 2015 | $413,000 | +1.5% | 9,958 | +10.1% | 0.00% | – |
| Q1 2015 | $407,000 | +42.8% | 9,045 | +22.9% | 0.00% | – |
| Q4 2014 | $285,000 | +8.8% | 7,358 | -2.1% | 0.00% | – |
| Q3 2014 | $262,000 | – | 7,513 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
| Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
| HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
| Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
| Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
| Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
| ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
| CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
| Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |